Position in NVS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$48,801,354
+$1,294,882 QoQ
Shares Held
311,392
+0.1% QoQ
Ownership
0.016%
of shares outstanding
% of Portfolio
0.58%
of 13F equity value
Holder Rank
#61
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 96%
Shared 0%
None 4%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026SATURNA CAPITAL CORP holds $1,106,352,364 across 8 Drug Manufacturers - General names. NVS ranks #5 (4.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
460,411 | $552,230,811 | |
| 2 | ABBV |
AbbVie Inc.
|
958,069 | $241,088,483 | |
| 3 | AZN |
Astrazeneca PLC
|
911,933 | $172,920,735 | |
| 4 | JNJ |
Johnson & Johnson
|
229,115 | $58,188,336 | |
| 5 | NVS |
Novartis AG
This page
|
311,392 | $48,801,354 | |
| 6 | MRK |
Merck & Co., Inc.
|
197,643 | $25,397,125 | |
| 7 | NVO |
Novo Nordisk A S
|
116,291 | $5,574,990 | |
| 8 | GSK |
GSK plc
|
41,025 | $2,150,530 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $48,801,354 | 311,392 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $47,506,472 | 311,008 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $43,106,709 | 312,662 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $40,434,200 | 315,301 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $38,224,154 | 315,876 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $35,692,105 | 320,166 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $31,165,084 | 320,266 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $36,578,430 | 318,018 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $34,749,927 | 326,413 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $31,716,219 | 327,884 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $33,083,426 | 327,656 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $33,558,897 | 329,461 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $31,450,216 | 311,666 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $28,544,472 | 310,266 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $28,186,341 | 310,696 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $24,795,602 | 326,215 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $27,553,229 | 325,958 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $28,583,509 | 325,738 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $28,001,596 | 320,128 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $26,274,114 | 321,278 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $25,882,324 | 283,673 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $24,017,572 | 280,973 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $28,012,942 | 296,653 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $25,756,943 | 296,193 | Shares | Sole | 2021-02-12 | |
| 2020-06-30 | $25,835,434 | 295,803 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $24,355,977 | 295,403 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||